Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms

Table 2

Risk of bias of the included studies.

Study	A	B	C	D	E	F	G	H	I	J	Total
Zhang (2010)	√		√			√	√				4
Wang (2016)	√		√			√					3
Chen (2012)	√		√			√					3
Leng (2015)	√		√			√				√	3
Liu (2012)	√		√			√	√				4
Liu (2008)	√		√			√					3
Li (2006)	√		√			√					3
Zeng (2003)	√		√			√					3
Wang (2008)	√	√	√			√			√	√	6
Wu (2012)	√	√	√			√	√		√	√	7

Studies fulfilling the criteria of the following: (A) peer reviewed publication; (B) control of temperature; (C) random allocation to treatment or control; (D) blinded induction of model; (E) blinded assessment of outcome; (F) use of anesthetic without significant intrinsic vascular protection activity; (G) appropriate animal model (aged, diabetic, or hypertensive); (H) sample size calculation; (I) compliance with animal welfare regulations; (J) statement of potential conflict of interests.